15:02 IST
BSE
Board Meeting Date
Samrat Pharmachem Board Meeting Date
Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.
Samrat Pharmachem Ltd
- Share price
- ₹232.00
- Market cap
- ₹71.68 Cr
- Revenue (annual)
- ₹289.7 Cr
- Net profit (annual)
- ₹-3.31 Cr
- P/E (TTM)
- -32.5×Sector 50.4×
- Promoter holding
- 49.09%+0.00% QoQ
- FII holding
- 3.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements
16:15 IST
BSE
Other Announcement
Samrat Pharmachem Other Announcement
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.
16:37 IST
BSE
Annual General Meeting
Samrat Pharmachem Annual General Meeting
Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.
20:15 IST
BSE
Financial Results
Samrat Pharmachem Q1 FY27 Results: Turns Profitable, Net Profit ₹0.9 Cr
Samrat Pharmachem Ltd reported revenue from operations of ₹79.8 Cr (+5.4% YoY) and net profit of ₹0.9 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.9 Cr
20:46 IST
BSE
Financial Results
Samrat Pharmachem Q4 FY26 Results: Net Loss of ₹2 Cr, Loss Widens
Samrat Pharmachem Ltd reported revenue from operations of ₹71.8 Cr (+0.8% YoY) and a net loss of ₹2 Cr for Q4 FY26.
- Key figure
- Net loss ₹2 Cr